Viewing Study NCT07249060

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-02-06 @ 9:13 AM
Study NCT ID: NCT07249060
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2025-11-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients
Sponsor: Hospital Universitario Araba
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Immune-Related Adverse Events View
None Lupus Erythematosus, Systemic View
None Sjogren Syndrome View
None Systemic Sclerosis (SSc) View
None Inflammatory Myopathies View
None Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immune Checkpoint Inhibitors View
None Adverse events View
None Biomarkers View
None Predictive View
None Prospective Studies View
None Immune System View